| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |